Our Mission

Globally, more than 5 million women are diagnosed each year across the most common cancers affecting women — including breast, lung, colorectal, uterine, ovarian, cervical, melanoma and brain cancer. This number is projected to rise materially by 2050.

Across the four largest English-speaking countries alone, more than 1.2 million women are diagnosed every year. Using the internationally recognised five-year benchmarks and a conservative 2.5 male-exposure multiplier, this equates to more than 15 million men directly connected to a woman’s cancer journey at any given time.

They are present in every room, in every treatment setting and in every home, where diagnosis reshapes daily life. Yet structurally, they remain largely unsupported. The Other Chair exists to address this global blind spot.

Women’s cancer incidence is projected to increase globally by approximately 30–40% by 2050.

If incidence rises proportionately across the US, UK, Canada and Australia, annual diagnoses across those four nations could move from more than 1.2 million to approximately 1.6 million per year.

Applying the same five-year survivorship framework and conservative exposure multiplier, the number of men connected to a woman’s cancer journey at any given time could exceed 20 million.

This is not a shrinking issue. It is a structural global trajectory. The Other Chair is being built to respond to that growth responsibly, credibly and at scale.

The Board comprises founding directors with experience across enterprise, governance and communications. Directors carry formal fiduciary responsibilities under Australian corporate and charity law.

Their role is to ensure that The Other Chair operates ethically, transparently and strictly within its stated charitable purpose, with international representation added as the platform expands.